Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Depolarizing neuromuscular block--a presynaptic mechanism?

S Feldman¹, J Hood

¹Magill Department of Anaesthetics, Charing Cross and Westminster Medical School, London, U.K.

Acta Anaesthesiologica Scandinavica

|August 1, 1994

Summary

Neuromuscular blocking drugs like decamethonium may not primarily act on the postsynaptic membrane. Recent evidence suggests these agents affect motor nerve terminals, influencing acetylcholine release.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial.

The Lancet. Respiratory medicine·2025

Same author

Performance and enteric methane emissions from housed beef cattle fed silage produced on pastures with different forage profiles.

Animal : an international journal of animal bioscience·2023

Same author

Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment.

Osteoarthritis and cartilage·2019

Same author

A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee.

Osteoarthritis and cartilage·2017

Same author

A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.

Osteoarthritis and cartilage·2017

Same author

Impact of a blood management protocol on transfusion rates and outcomes following total hip and knee arthroplasty.

Annals of the Royal College of Surgeons of England·2016

Area of Science:

Pharmacology
Neuroscience
Neuromuscular Junction Physiology

Background:

Decamethonium and suxamethonium are known acetylcholine agonists at the neuromuscular junction.
Their neuromuscular block is traditionally attributed to postsynaptic depolarization and desensitization.
Previous evidence suggested a role for these drugs at motor nerve terminals, but this was largely overlooked.

Purpose of the Study:

To re-evaluate the mechanism of neuromuscular blockade induced by decamethonium and suxamethonium.
To present evidence challenging the postsynaptic theory of action for these drugs.
To propose and support an alternative presynaptic mechanism involving acetylcholine release.

Main Methods:

Review of existing evidence regarding drug action on motor nerve terminals.

Related Experiment Videos

Presentation of results from recent experiments investigating drug effects.

Analysis of findings to support a presynaptic hypothesis.

Main Results:

Evidence questioning the sole reliance on postsynaptic depolarization or desensitization was presented.
Recent experimental results are more consistent with a presynaptic mechanism.
These drugs appear to initially stimulate then depress acetylcholine release from motor nerve terminals.

Conclusions:

The neuromuscular block induced by decamethonium and suxamethonium is better explained by a presynaptic action.
These drugs modulate acetylcholine release, causing initial stimulation followed by depression.
A shift in understanding from postsynaptic to presynaptic effects is warranted for these neuromuscular blocking agents.